
Ovarian cancer and RGCC testing
Recurrent epithelial ovarian cancer is a sequencing problem. CTC-guided therapy is one of the few published ways to make that sequence less blind. Hong Kong

Recurrent epithelial ovarian cancer is a sequencing problem. CTC-guided therapy is one of the few published ways to make that sequence less blind. Hong Kong

When time is short and standard lines are few, a functional profile of circulating tumour cells can help the team choose the next move faster.

A liquid-biopsy approach for a cancer that Hong Kong still sees too often, in patients who often cannot spare another invasive procedure. Hong Kong context

When PSA, MRI and biopsy do not tell the whole story — using CTCs to watch activity and to choose the next systemic option. Hong

A blood-based layer for the most common cancer in Hong Kong, where driver mutations, never-smokers and rapid resistance all make a single protocol a poor

Using circulating tumour cells to monitor residual disease and to choose the next line when colorectal cancer has already been through standard protocols. Hong Kong

Personalising screening, monitoring and treatment choices when the most common female cancer in Hong Kong is not one disease. Hong Kong context In 2023 the

高劑量維他命c與癌細胞的讨论,不能只看实验室结果。本文说明静脉高剂量维生素C在整合肿瘤支持中的现有证据、可能作用、安全筛查、治疗配合原则,以及何时应与肿瘤科团队共同制定个体化计划,兼顾疗效期待与生活质量。帮助患者和家属在积极寻求支持治疗时,作出更审慎、可执行的医疗选择,并持续监测身体反应与治疗进程变化。

高劑量維他命c與癌症的關係,不能只看「抗癌」二字。本文說明靜脈高劑量維他命C在整合腫瘤照護中的現有證據、可能改善的生活品質、與化療及標靶治療併用時的注意事項,以及腎功能、G6PD缺乏、治療時程與個人化安全評估,幫助患者及家屬在醫療監督下作出務實選擇。並建立以治療目標及檢驗結果為本的支援計劃。更安心。

高劑量維他命c並非人人適合。本文說明靜脈營養治療的可能角色、腎功能與藥物風險、癌症治療期間的協調原則,以及如何透過病史、血液檢測和個人化醫療評估,制定以安全、生活品質與持續追蹤為核心的支持計劃,讓患者和家人在每一個療程階段都能作出更有根據、更安心的健康決定,並與主診醫生保持清晰溝通,獲得合適照護和作出安排。